Active	Status	Sponsor type	Region	Phase	Filter
3 Active 5 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
CodaVax-RSV / Codagenix
NCT04919109: Safety and Immunogenicity of CodaVax-RSV in Seropositive and Seronegative Children	Active, not recruiting	1	51	US, RoW	CodaVax-RSV, Normal Saline	Codagenix, Inc	Respiratory Syncytial Virus Infections	04/25	08/25
CodaLytic / Codagenix
NCT05600582: A Study of CodaLytic, an Intratumoral Oncolytic Virus, in Patients With Breast Cancer	Withdrawn	1	24	US	CodaLytic	Codagenix, Inc	Breast Neoplasms, Neoplasm Metastasis	09/24	01/25
live attenuated influenza H1N1 vaccine (CODA-VAX H1N1) / Codagenix
NCT05223179: Intramuscular CodaVax-H1N1 in Healthy Adults	Completed	1	69	RoW	CODA-VAX H1N1, Flucelvax Quad, Saline	Codagenix, Inc	Influenza, Human	02/24	02/24

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
CodaVax-RSV / Codagenix
NCT04919109: Safety and Immunogenicity of CodaVax-RSV in Seropositive and Seronegative Children	Active, not recruiting	1	51	US, RoW	CodaVax-RSV, Normal Saline	Codagenix, Inc	Respiratory Syncytial Virus Infections	04/25	08/25
CodaLytic / Codagenix
NCT05600582: A Study of CodaLytic, an Intratumoral Oncolytic Virus, in Patients With Breast Cancer	Withdrawn	1	24	US	CodaLytic	Codagenix, Inc	Breast Neoplasms, Neoplasm Metastasis	09/24	01/25
live attenuated influenza H1N1 vaccine (CODA-VAX H1N1) / Codagenix
NCT05223179: Intramuscular CodaVax-H1N1 in Healthy Adults	Completed	1	69	RoW	CODA-VAX H1N1, Flucelvax Quad, Saline	Codagenix, Inc	Influenza, Human	02/24	02/24